DFB Pharmaceuticals
Practical innovations for life

Phyton Biotech

API Development and Manufacturing via Plant Cell Fermentation.


Commercial scale plant cell fermentation technology

DFB owns and operates Phyton Biotech®

  • The world’s first and only company to harness plant cell fermentation (PCF®) technology for both paclitaxel and docetaxel API

  • Among the world’s largest commercial producers of high-quality paclitaxel and docetaxel API

  • Only paclitaxel and docetaxel API supplier in the world not relying on yew tree plantation-derived 10-DAB decreasing risk of drug shortage and offering unparalleled environmental responsibility

  • Development services and commercialization of plant-derived actives via PCF® in pharmaceutical, nutraceutical, and related indstries

  • Recombinant human protein development capability via proprietary plant Universal Hostsystem

visit phyton biotech >